Zuretinol acetate

DB12112InvestigationalSmall molecule

Zuretinol acetate has been used in trials studying the treatment of Impaired Dark Adaptation, RP (Retinitis Pigmentosa), Retinitis Pigmentosa (RP), and LCA (Leber Congenital Amaurosis).

Formula / weight: C₂₂H₃₂O₂ · 328.4883 g/mol (avg)
Code names: QLT-091001

Resolves to

Compound

UNII2K3YP54BYUCAS29584-22-3PubChem10245972

Structure

InChIKeyQGNJRVVDBSJHIZ-AQDFTDIISA-NSMILESCC(=O)OC\C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C

Targets

O95237LRATQ16518RPE65

What you can answer from here — as of July 07, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

47Drug interactionsStructured to mechanism, not free text

5Clinical trialsPhase, status and sponsor resolved per trial

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with Zuretinol acetate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account